Avion Group B.V. has raised US$11.5m growth capital from a group of investors led by Kempen
A group of investors led by Kempen Private Markets has invested US$11.5 million in Avion Group B.V. (Avion) to fund the development of its second training center with an in-house developed simulator, for which Avion already signed a contract with the UK flight school IAGO to set up this training center in London. In addition, the funding will be used to further develop the existing simulator.
Avion is a Dutch developer and manufacturer of high-tech full flight motion simulators. Avion has a fully certified Airbus A320 simulator operational in its own training center on Malta from where it serves several airlines that train their pilots at Avion's center.
Oaklins' team in the Netherlands acted as fundraising advisor to Avion and its shareholders.
Neem contact op met het dealteam
Gerelateerde deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Lees verderSRT Marine has completed a placing and subscription
SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.
Lees verderIXICO has completed a fundraising
IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.
Lees verder